Age and Human Regenerative Capacity: Impact of Cardiovascular Risk Factors

Circulation Research

Volumn 119, Issue 7, 2016, Pages 801-809

  Al Mheid, Ibhar ^a   Hayek, Salim S ^a   Ko, Yi An ^a   Akbik, Faysal ^a   Li, Qunna ^a   Ghasemzadeh, Nima ^a   Martin, Greg S ^a   Long, Qi ^a   Hammadah, Muhammad ^a   Maziar Zafari, A ^a   Vaccarino, Viola ^a   Waller, Edmund K ^a   Quyyumi, Arshed A ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

aging; cardiovascular risk factors; progenitor cells

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; VASCULOTROPIN RECEPTOR 2;

ADULT; AGE DISTRIBUTION; AGED; AGING; ANTIGEN EXPRESSION; ARTICLE; BODY SIZE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COUNT; CELL STIMULATION; CIRCULATING PROGENITOR CELL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGENERATIVE ABILITY; SEX DIFFERENCE; SMOKING; STEM CELL; STEM CELL MOBILIZATION; ADOLESCENT; BLOOD; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; REGENERATION; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CELL COUNT; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; REGENERATION; RISK FACTORS; STEM CELLS; YOUNG ADULT;

EID: 84980007058     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.308461     Document Type: Article

References (40)

1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM, Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999 85 221 228
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 964 967
3. Gehling UM, Ergün S, Schumacher U, Wagener C, Pantel K, Otte M, Schuch G, Schafhausen P, Mende T, Kilic N, Kluge K, Schäfer B, Hossfeld DK, Fiedler W, In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000 95 3106 3112
4. Urbich C, Dimmeler S, Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004 95 343 353. doi: 10.1161/01.RES.0000137877.89448.78
5. Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, Hulbert C, Gavin M, Hanley A, Ma H, Kearney M, Zak V, Asahara T, Losordo DW, CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006 114 2163 2169. doi: 10.1161/CIRCULATIONAHA.106.644518
6. Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo GR, Terstappen L, The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood 1995 85 2422 2435
7. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW, AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997 90 5002 5012
8. Fadini GP, Losordo D, Dimmeler S, Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012 110 624 637. doi: 10.1161/CIRCRESAHA.111.243386
9. Case J, Mead LE, Bessler WK, Prater D, White HA, Saadatzadeh MR, Bhavsar JR, Yoder MC, Haneline LS, Ingram DA, Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol 2007 35 1109 1118. doi: 10.1016/j.exphem.2007.04.002
10. Alaiti MA, Ishikawa M, Costa MA, Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy. Transl Res 2010 156 112 129. doi: 10.1016/j.trsl.2010.06.008
11. Seeger FH, Rasper T, Koyanagi M, Fox H, Zeiher AM, Dimmeler S, CXCR4 expression determines functional activity of bone marrow-derived mononuclear cells for therapeutic neovascularization in acute ischemia. Arterioscler Thromb Vasc Biol 2009 29 1802 1809. doi: 10.1161/ATVBAHA.109.194688
12. Al Mheid I, Quyyumi AA, Cell therapy in peripheral arterial disease. Angiology 2008 59 705 716. doi: 10.1177/0003319708321584
13. Poole J, Mavromatis K, Binongo JN, Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial. JAMA 2013 310 2631 2639. doi: 10.1001/jama.2013.282540
14. Leone AM, Rutella S, Bonanno G, Contemi AM, de Ritis DG, Giannico MB, Rebuzzi AG, Leone G, Crea F, Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol 2006 111 202 208. doi: 10.1016/j.ijcard.2005.06.043
15. Wojakowski W, Tendera M, Michałowska A, Majka M, Kucia M, Maślankiewicz K, Wyderka R, Ochała A, Ratajczak MZ, Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004 110 3213 3220. doi: 10.1161/01.CIR.0000147609.39780.02
16. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki K, Shimada T, Oike Y, Imaizumi T, Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001 103 2776 2779
17. Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M, Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007 83 598 605. doi: 10.1016/j.athoracsur.2006.09.087
18. Fox A, Smythe J, Fisher N, Tyler MP, McGrouther DA, Watt SM, Harris AL, Mobilization of endothelial progenitor cells into the circulation in burned patients. Br J Surg 2008 95 244 251. doi: 10.1002/bjs.5913
19. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S, Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001 88 167 174
20. Sepp D, Franz D, Triftshaeuser N, Ott I, Esposito-Bauer L, Feurer R, Seifert CL, Thaler M, Hemmer B, Poppert H, Mobilization of CD133+ progenitor cells in patients with acute cerebral infarction. PLoS One 2014 9 e70796. doi: 10.1371/journal.pone.0070796
21. Hu T, She Q, Jiang Y, Su L, Yin Y, Level of CD14+-endothelial progenitor cells is not associated with coronary artery disease or cardiovascular risk factors. Age (Dordr) 2008 30 319 326. doi: 10.1007/s11357-008-9074-z
22. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T, Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003 348 593 600. doi: 10.1056/NEJMoa022287
23. Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S, Zeiher AM, de Kreutzenberg S, Avogaro A, Nickenig G, Schmidt-Lucke C, Werner N, Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One 2010 5 e11488. doi: 10.1371/journal.pone.0011488
24. Lenfant C, Chobanian AV, Jones DW, Roccella EJ, Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension 2003 41 1178 1179. doi: 10.1161/01.HYP.0000075790.33892.AE
25. Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA, Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ, Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001 345 1583 1592. doi: 10.1056/NEJMoa011090
26. Genuth S, Alberti KG, Bennett P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003 26 3160 3167
27. Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I, The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996 5 213 226. doi: 10.1089/scd.1.1996.5.213
28. Al Mheid I, Corrigan F, Shirazi F, Veledar E, Li Q, Alexander WR, Taylor WR, Waller EK, Quyyumi AA, Circadian variation in vascular function and regenerative capacity in healthy humans. J Am Heart Assoc 2014 3 e000845. doi: 10.1161/JAHA.114.000845
29. Zheng H, Fu G, Dai T, Huang H, Migration of endothelial progenitor cells mediated by stromal cell-derived factor-1alpha/CXCR4 via PI3K/Akt/eNOS signal transduction pathway. J Cardiovasc Pharmacol 2007 50 274 280. doi: 10.1097/FJC.0b013e318093ec8f
30. Zhu S, Liu X, Li Y, Goldschmidt-Clermont PJ, Dong C, Aging in the atherosclerosis milieu may accelerate the consumption of bone marrow endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2007 27 113 119. doi: 10.1161/01.ATV.0000252035.12881.d0
31. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, Pippen AM, Annex BH, Dong C, Taylor DA, Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003 108 457 463. doi: 10.1161/01.CIR.0000082924.75945.48
32. Cohen KS, Cheng S, Larson MG, Cupples LA, McCabe EL, Wang YA, Ngwa JS, Martin RP, Klein RJ, Hashmi B, Ge Y, O'Donnell CJ, Vasan RS, Shaw SY, Wang TJ, Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors. Blood 2013 121 e50 e56. doi: 10.1182/blood-2012-05-424846
33. Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, Dimmeler S, Zeiher AM, Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005 111 2981 2987. doi: 10.1161/CIRCULATIONAHA.104.504340
34. + progenitor cells and risk of mortality in a population with coronary artery disease. Circ Res 2015 116 289 297. doi: 10.1161/CIRCRESAHA.116.304187
35. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G, Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005 353 999 1007. doi: 10.1056/NEJMoa043814
36. Abkowitz JL, Robinson AE, Kale S, Long MW, Chen J, Mobilization of hematopoietic stem cells during homeostasis and after cytokine exposure. Blood 2003 102 1249 1253. doi: 10.1182/blood-2003-01-0318
37. Körbling M, Haas R, Knauf W, Holle R, Hunstein W, Therapeutic efficacy of autologous blood stem cell transplantation (ABSCT): the role of cytotoxic/cytokine stem cell mobilization. Bone Marrow Transplant 1990 5 suppl 1 39 40
38. Lavazais E, Pogu S, Saï P, Martignat L, Cytokine mobilization of bone marrow cells and pancreatic lesion do not improve streptozotocin-induced diabetes in mice by transdifferentiation of bone marrow cells into insulin-producing cells. Diabetes Metab 2007 33 68 78. doi: 10.1016/j.diabet.2006.11.002
39. Povsic TJ, Najjar SS, Prather K, EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy. J Thromb Thrombolysis 2013 36 375 383. doi: 10.1007/s11239-013-0944-6
40. Quyyumi AA, Waller EK, Murrow J, CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. Am Heart J 2011 161 98 105. doi: 10.1016/j.ahj.2010.09.025